Polaris Market Research today announced findings from its latest report, projecting the global Enzymatic DNA Synthesis Market to grow from USD 284.26 Million in 2024 to USD 3,063.36 Million by 2034, at a CAGR of 26.85%, with the market already valued at USD 360.17 Million in 2025. The report profiles 15 leading companies across four core market segments.

Analyst Commentary on Enzymatic DNA Synthesis Market Growth

“Enzymatic DNA synthesis is moving from a niche laboratory technique to a mainstream biomanufacturing tool, as biotech firms and contract research organizations push for faster, cleaner sequence production,” said a Polaris Market Research analyst covering the biotechnology practice. “Buyers evaluating market entry should watch synthetic biology and vaccine-development applications, where enzymatic platforms are displacing chemical synthesis fastest.”

Enzymatic DNA Synthesis Market Statistics at a Glance

• 2024 Market Size: USD 284.26 Million
• 2034 Projected Size: USD 3,063.36 Million
• CAGR (2025-2034): 26.85%
• Largest Region (2024): North America

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: an expanding biotechnology sector spanning biopharma, agricultural and industrial biotech, rising research funding for genomics and drug development, and the growing use of AI and machine learning for automated sequence design and error correction are the primary forces behind the market's expansion, alongside rising demand for synthetic biology applications. In May 2025, Telesis Bio licensed its Gibson SOLA enzymatic synthesis platform to Regeneron, cutting DNA and mRNA production timelines from weeks to hours.

Major Companies Covered: DNA Script SAS, Twist Bioscience Corporation, Molecular Assemblies, Inc., Aldevron LLC (Danaher Corporation), and GenScript Biotech Corporation.

Segments Covered: By Services (Oligonucleotide Synthesis, Gene Synthesis), By Technology (SOLA, CRISPR, PCR), By Application (Synthetic Biology, Genetic Engineering, Vaccine Development, Others), By End Use (Biopharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations), By Region.

By services, oligonucleotide synthesis accounted for the largest revenue share in 2024 on the strength of its use in molecular diagnostics, PCR assays, and drug discovery, while gene synthesis is set to expand fastest as adoption spreads across synthetic biology and genetic engineering. By technology, PCR led in 2024 given its established role in disease detection, though CRISPR is forecast to grow fastest as genome-editing and therapeutic research programs scale up. High R&D costs and limited commercial-scale production capacity remain the market's principal restraints, particularly for smaller research institutes.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/enzymatic-dna-synthesis-market 

Recent Developments in the Enzymatic DNA Synthesis Market

• May 2025: Ansa Biotechnologies unveiled a 50 kb DNA synthesis early access program capable of producing ultra-long, intricate DNA sequences within four weeks.
• May 2025: Telesis Bio granted Regeneron a license to its Gibson SOLA enzymatic synthesis platform for on-demand, high-throughput gene synthesis.
• February 2025: Backed by USD 4.7 million in CEPI funding, Paris-based researchers working with DNA Script advanced enzymatic DNA synthesis for mRNA vaccine production, aiming to shorten vaccine timelines and widen access across the Global South.

Regional Snapshot: North America Leads, Asia Pacific Fastest-Growing

North America held the largest share in 2024, supported by a dense cluster of biotech and pharma players and robust NIH and private investment in genomics and precision medicine, with the U.S. benefiting from an established base of contract research organizations and academic institutions. Asia Pacific is projected to register the fastest growth through 2034 on the back of government-backed synthetic biology programs and expanding pharmaceutical manufacturing hubs, with China advancing rapidly on the strength of large-scale state-backed venture funding for biotech and AI. Europe also held a significant share in 2024, driven by EU-funded genomics initiatives and a strong regional emphasis on green chemistry and sustainable synthesis methods.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the DNA synthesis market forecast, the underlying report benchmarks Enzymatic DNA Synthesis Market share, company positioning, and segment-level forecasts to support sourcing, partnership, and investment decisions through 2034. The full report additionally profiles the competitive strategies of leading enzymatic synthesis providers, giving buyers and investors a clearer view of where consolidation, licensing deals, and capacity expansion are likely to occur next.

More Trending Latest Reports By Polaris Market Research:

Pulses Market

Biomaterials Market

Welding Materials Market

Protein A, G, and L Resins Market

Biomaterials Market

Agricultural Robots Market

Propionic Acid Market

Plasma Powder Market: A Nutritious Value Addition to Pet Food

Europe Antibody Specificity Testing Market